THEOCHRON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Theochron, and what generic alternatives are available?
Theochron is a drug marketed by Nostrum Pharms Llc and is included in one NDA.
The generic ingredient in THEOCHRON is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Theochron
A generic version of THEOCHRON was approved as theophylline by RHODES PHARMS on September 1st, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THEOCHRON?
- What are the global sales for THEOCHRON?
- What is Average Wholesale Price for THEOCHRON?
Summary for THEOCHRON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 139 |
Patent Applications: | 3,990 |
DailyMed Link: | THEOCHRON at DailyMed |
Pharmacology for THEOCHRON
Drug Class | Methylxanthine |
US Patents and Regulatory Information for THEOCHRON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-003 | Feb 21, 1985 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-005 | Aug 9, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-004 | Feb 21, 1985 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Pharms Llc | THEOCHRON | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-002 | Jan 11, 1983 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |